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Abstract: 
The development of reliable methods for restoring susceptibility after antibiotic 
resistance arises has proven elusive.  A greater understanding of the relationship 
between antibiotic administration and the evolution of resistance is key to 
overcoming this challenge.  Here we present a data-driven mathematical 
approach for developing antibiotic treatment plans that can reverse the evolution 
of antibiotic resistance determinants.  We have generated adaptive landscapes 
for 16 genotypes of the TEM β-lactamase that vary from the wild type genotype 
“TEM-1” through all combinations of four amino acid substitutions. We 
determined the growth rate of each genotype when treated with each of 15 β-
lactam antibiotics.  By using growth rates as a measure of fitness, we computed 
the probability of each amino acid substitution in each β-lactam treatment using 
two different models named the Correlated Probability Model (CPM) and the 
Equal Probability Model (EPM).  We then performed an exhaustive search 
through the 15 treatments for substitution paths leading from each of the 16 
genotypes back to the wild type TEM-1.  We identified those treatment paths that 
returned the highest probabilities of selecting for reversions of amino acid 
substitutions and returning TEM to the wild type state.  For the CPM model, the 
optimized probabilities ranged between 0.6 and 1.0.  For the EPM model, the 
optimized probabilities ranged between 0.38 and 1.0. For cyclical CPM treatment 
plans in which the starting and ending genotype was the wild type, the 
probabilities were between 0.62 and 0.7.  Overall this study shows that there is 
promise for reversing the evolution of resistance through antibiotic treatment 
plans. 
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Blurb: We explore a novel approach to antibiotic cycling based on evolutionary 
adaptive landscapes and mathematical optimization of antibiotic treatments. It 
shows that antibiotic cycling can reverse the evolution of antibiotic resistance. 
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Introduction 
Antibiotic resistance is an inevitable outcome whenever antibiotics are used. 
There are many reasons for this: 1) As humans (also as eukaryotes), we are 
vastly outnumbered by bacteria in nearly all measures, including total population 
size, biomass, genetic diversity, emigration, and immigration [1]; 2) bacteria can 
use horizontal gene transfer to share resistance genes across distantly related 
species of bacteria, including non-pathogens [2]; 3) compared to humans, 
bacteria have relatively few vulnerable target sites [3]; 4) microbes are the 
sources of nearly all antibiotics that are used by humans [4]. Given the 
overwhelming numbers of bacteria, the limited number of target sites, the 
numerous ways that they can infect humans, and that they have been exposed to 
naturally occurring antibiotics for billions of years, resistance to antibiotics used 
by human populations is unavoidable.  
 
Once resistance is present in a bacterial population, it is exceedingly difficult to 
remove for several reasons. If any amount of antibiotic is present in the 
environment, antibiotic resistance genes will confer a large fitness advantage [5], 
and even when antibiotics are not present in an environment, the fitness costs for 
carrying and expressing resistance genes are small to non-existent [6]. In 
addition to it being difficult to remove antibiotics from the environment [7], even if 
humans were to completely abandon the use of antibiotics, resistance would 
persist for years [8].  
 
Efforts to remove resistance genes from clinical environments by either 
discontinuing or reducing the use of specific antibiotics for some period of time, 
either through general reduction of antibiotic consumption or periodic rotations of 
antibiotics (cycling) have not worked in any reliable or reproducible manner [9]; 
indeed it would have been surprising if they had worked [10],[11].  
 
Since antibiotic resistance is unavoidable, it only makes sense to accept its 
inevitability and develop methods for mitigating the consequences. One 
reasonable approach is to rotate the use of antibiotics. This has been 
implemented in many ways and there are recent studies to model the optimal 
duration, mixing versus cycling, and how relaxed antibiotic cycles may be and still 
function as planned [12,13]. However, none of those models have focused on 
developing a method for designing an optimal succession of antibiotics.  
 
In a previous publication [14], we proposed that susceptibility to antibiotics could 
be restored by rotating consumption of multiple antibiotics that are a) structurally 
similar, b) inhibit/kill bacteria through the same target site, and c) result in 
pleiotropic fitness costs that reduce the overall resistance of bacteria to each 
other. We presented a proof-of-principle example [14] of how this might work with 
a series of β-lactam antibiotics in which some of them would select for new 
amino acid substitutions in the TEM β-lactamase and others that would select 
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reversions in TEM ultimately leading back to the wild type (un-mutated) state.  
We have focused particularly on β-lactamases because there is often no fitness 
cost associated with their expression, and they are particularly difficult to remove 
from clinical microbial populations.    
 
Our current work seeks to identify β-lactam treatment plans that have the highest 
probability of returning a population expressing a small number of variant TEM 
genotypes to the wild type state. The wild type TEM-1, and a handful of its 
descendants, confers resistance to penicillins alone. However, most of the 
descendants confer resistance to either cephalosporins or penicillins combined 
with β-lactamase inhibitors (inhibitor resistance), and a few confer resistance to 
both. Of the 194 clinically identified TEM genotypes that encode unique amino 
acid sequences [15], 174 (89.7%) differ from the wild type TEM-1 by at most four 
amino acid substitutions (see Table 1). Our choice of a system that includes four 
amino acid substitutions is based upon an apparent threshold for amino acid 
substitutions among functional TEM genotypes. The rarity of the co-existence of 
cephalosporin resistance and inhibitor resistance and the fact that no single 
substitution confers both phenotypes suggested that sign epistasis (i.e. reversals 
of substitutions from beneficial to detrimental) exists as the substitutions that 
contribute to this dual phenotype are combined. 
 
The ability to apply selective pressures that favor reversions of substitutions 
within an evolved TEM genotype would increase the number of antibiotics that 
could be used. To embark upon our effort of determining the best way to do this, 
we decided to create a model system based upon the TEM-50 genotype, which 
differs from TEM-1 by four amino acid substitutions. All four substitutions by 
themselves confer clearly defined resistance advantages in the presence of 
certain antibiotics. Additionally, TEM-50 is one of the few genotypes that 
simultaneously confers resistance to cephalosporins and inhibitor combined 
therapies.  
 
Results 
From experimental data to mathematical models  
 
We created all 16 variant genotypes of the four amino acid substitutions found in 
TEM-50 using site directed mutagenesis (Table 2) and measured the growth 
rates of 12 replicates of E.coli DH5α-E expressing each genotype in the 
presence of one of fifteen β-lactam antibiotics (Table 3). Each genotype was 
grown in each antibiotic in 12 replicates. We computed the mean growth rate of 
those replicates (Table 4) and the variance of each sample, as well as the 
significance between adjacent genotypes that differed by one amino acid 
substitution. This was done using one-way ANOVA analysis.  
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The results are summarized in Figures 1-15, where the arrows in the fitness 
graphs connect pairs of adjacent genotypes. For each comparison of adjacent 
genotypes, we indicate the one whose expression resulted in the faster growth by 
directing the arrowhead towards that genotype, and implying that evolution would 
proceed in that direction if the two genotypes occurred simultaneously in a 
population [16,17]. In other words, the node indicated by the arrowhead would 
increase in frequency and reach fixation in the population, while the other would 
be lost. Red arrows indicate significance, and black arrows indicate differences 
that were not statistically significant by ANOVA, but that may still exist if a more 
sensitive assay was used. 
 
We rank ordered the genotypes (Table 5) in each landscape diagram with a 
score from 1 to 16, with the genotype promoting the fastest growth receiving a 
score of “1” and the genotype with the slowest growth a score of “16”.  This 
analysis shows that all genotypes have a score of 5 or better and a score of 13 or 
worse, in at least one landscape, indicating that there is abundant pleiotropy as 
antibiotic selective pressures change. That pleiotropy provides a basis for 
effectively alternating antibiotic to restore the wild type. 
 
Based on the strong patterns of pleiotropy we observed, we reasoned that the 
choice and the succession of antibiotics were at least as important as other 
cycling considerations. We formalized our approach to identifying optimal 
antibiotic treatment paths as follows. 
 
We considered the 15 antibiotics previously mentioned in Table 3: AMP, AM, 
CEC, CTX, ZOX, CXM, CRO, AMC, CAZ, CTT, SAM, CPR, CPD, TZP, and FEP 
and their interactions with a bi-allelic 4-locus TEM system {0,1}4  where four 
functionally important amino acid residues involved in the evolution of TEM-50 
are considered.  The number "1" denotes an amino acid substitution, whereas "0" 
denotes no substitution at the site.  We experimentally determined growth rates 
for all genotypes in our TEM system at a selected concentration of each 
antibiotic.  Those growth rates depend upon the states of the four amino acid 
residues. The growth rates for all genotypes in one antibiotic can be represented 
by a real 2 × 2 × 2 × 2  tensor f = ( fijkl ) , where f (ar )  is the fitness landscape for 
the antibiotic r . We can identify f (ar )  with a vector whose coordinates are 
indexed by {0,1}4 .  The resulting 15 vectors, one for each antibiotic, are the rows 
in Table 4.  
 
Our substitution modelM ( f )  is a function  M :16→ 16x16  that assigns a 
transition matrix to each fitness landscape.   The rows and columns of M ( f )  are 
labeled by the genotypes {0,1}4  ordered from 0000 to 1111 according to the 
degree of lexicographic order. The entries in M ( f (ar ))u ,v  represent the probability 
that that genotype u  is replaced by genotype v  under the presence of antibiotic 
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ar . For that reason, the rows of our transition matrices have nonnegative entries 
and their rows sum to 1.  
 
We require that our transition matrices respect the adjacency structure of the 4-
cube, that is, M ( f )u ,v = 0  unless u  and v  are vectors in {0,1}4  that differ in at 
most one coordinate.  In other words, we reasoned that resistant strains are most 
likely to be in competition with those that express resistance genotypes that are 
immediately adjacent (vary by a single amino acid substitution).  
 
 
The combined effect of a sequence a1,...,ak  of k  antibiotics is described by a 
new transition matrix  
 M ( fa1 ) ⋅M ( fa2 ) ⋅⋅⋅⋅⋅M ( fak ) ,  
obtained as the product of the transition matrices for each drug .  
For any genotype u other than 0000, our goal is to find a sequence of antibiotics 
which maximizes the probability of returning to the wild type. In other words, if we 
restrict to sequences of length k our goal is to find a sequence of antibiotics 
a1,...,ak  which maximizes the matrix entry M ( f (a1)) ⋅M ( f (a2 )) ⋅...⋅M ( f (ak ))u ,0000 . 
For each u  this requires searching over all  antibiotic sequences of length k . 
 
Finding optimal sequences of antibiotics  
We used two substitution models to determine the optimal (most probable) 
sequences of β-lactams for returning TEM genotypes back to their wild type 
state. Briefly, the Correlated Probability Model (CPM) allows probabilities to be 
based upon the actual growth rates. It is given by applying equation (3) to the 
growth rates in Table 4. The Equal Probability Model (EPM) assumes that 
beneficial mutations are equally likely and that only the direction of the arrows in 
Figures 1-15 is important. This means that the matrix entry M ( f )u ,v  is 1/ N  if 
genotype u  has N  outgoing arrows and there is an arrow from u  to v .   
 
A visual summary of the highest probabilities according to the CPM is provided in 
Figure 16. The CPM provides good estimates if fitness differences between 
genotypes are small [14,18,19,20]. The EPM has been used in settings where 
only rank order (as in Table 5) is available [21]. 
 
For all sequences of antibiotics of a fixed length (two, three, four, five, and six), 
we examined the probability that a given genotype is returned to the wild type 
state. For every starting genotype, we found we were able to return to the wild 
type genotype with a probability between 0.6 and 1.0 when using the CPM model 
and a probability of 0.375 and 1.0 when using the EPM model.  These results are 
summarized in Tables 6-9 and Figure 17.  These results show the number of 
paths and their probabilities (Tables 6 and 7) and the substitutions of the most 
probable paths (Tables 8-11) for returning to the wild type state from various 
15k
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starting points.  
 
Once returned to the wild type state, we identified cycles that would allow for 
alternation of antibiotics, and allow for some variation through amino acid 
substitution, but then rapidly return bacteria to the wild type state (Figure 18). 
Such cycles were possible for path length of two, four, and six and the 
probabilities of those paths were respectively 0.704, 0.617, 0.617.  We found that 
in the most probable cases, the genotype varied by only one amino acid 
substitution before reverting back to the wild type state. However, when 
treatment plans with lower probabilities are considered, we find that more amino 
acid substitutions in the genotype are allowed.  
 
Discussion 
In this study, we have developed an experimental approach for measuring 
pleiotropy and a computational mathematical approach for optimizing antibiotic 
treatment paths. The experimental approach we developed is rapid and high 
throughput, and should be applicable to many species of resistant bacteria. The 
mathematical model we created expresses the problem of antibiotic resistance in 
general terms, and can therefore be applied to other resistance phenotypes 
where pleiotropy occurs to identify the antibiotic treatment plans that have the 
highest probability of reversing the evolution of resistance.  
 
The purpose of this study was to determine whether it is possible to use selective 
pressures to return TEM-genotypes to the wild type state, as observed in 1963 
when TEM-1 was originally isolated.  The methods may also be used to select for 
any particular genotype within our data set. As such, we may select with 
reasonably high probabilities, resistance genotypes that existed at some prior 
point in time. To highlight this feature, we have named our software package 
“Time Machine”. 
 
Once given growth rates of adjacent genotypes, Time Machine returned 
treatment plans that restored the wild type state as observed in 1963 with 
probabilities greater than 0.6 when using the CPM model and greater than 3/8 
(>0.375) when using EPM.  These results suggest that when possible it is 
desirable to use actual growth rates rather than rough ranking data. 
 
The discrete optimization problem motivated by our goal to reverse resistance, or 
the challenge to build a better time machine, is of independent mathematical 
interest. Tables 6 and 7 suggest that the maximum probabilities in each row 
stagnate after a limited number of steps. This is not always the case. We have 
created an example (see supplemental information) of two substitution matrices 
on a 3-locus system where the maximum probabilities can be increased 
indefinitely. 
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These results show that great potential exists for remediation of antibiotic 
resistance through antibiotic treatment plans when pleiotropic fitness costs are 
known for an appropriate set of antibiotics.  While developed using a model of 
Gram-negative antibacterial resistance, this approach could also be used for 
Gram-positive bacteria and HIV treatment plans.  
 
Methods 
Experimental methods 
Strains and Cultures 
We expressed 16 mutant constructs of the blaTEM gene in plasmid pBR322 from 
strain DH5-αE. The 16 genotypes differ at all combinations of four amino acid 
residues and have been previously described [14]. We grew them overnight (16 
hours) in standing cultures and diluted them to a concentration of 1.9X105 as 
described elsewhere [14].  
 
We transferred 80 µl of each culture to a 384-well plate with one genotype 
present in each of the 16 rows. The first 12 wells of each row were antibiotic free 
(controls) and the last 12 wells contained a single antibiotic at an inhibitory, 
sublethal concentration  
 
After plating, a membrane is placed over the plate and simultaneously 
incubated/measured in the Eon Microplate Spectrophotometer at a temperature 
of 25.1°C for 22 hours. This relatively cool (<37º) temperature is used because 
degradation of the antibiotics is much slower, while the growth rate of the 
bacteria is still sufficient to capture the complete exponential period of growth 
over the duration of the experiment. Overall, we have found that a temperature 
~25ºC yields more reliable and consistent measurement of growth rates in the 
presence of antibiotics.  
 
Measurements of cell density (light scattering) at a wavelength of 600 
nanometers were automatically collected every 20 minutes after brief agitation to 
homogenize and oxygenate the culture.  
 
Growth Rates 
The data obtained from the microplate spectrophotometer is exported to the 
GrowthRates program to derive the growth rates. In essence, by measuring the 
optical density at frequent intervals the GrowthRates program can estimate the 
growth rate,α, through a linear regression algorithm fitting the data from the 
exponential growth phase. Details can be found in [22] in the section entitled 
“The Growth Curve” located on pages 233-4. The output of this program for the 
data we collected was a list f (a1), f (a2 ),..., f (ak )  of 15 tensors, each of format
2 × 2 × 2 × 2 . These are the rows in Table 4. So if u ∈{0,1}4  is a genotype, then 
f (ai )u  is the fitness of genotype u  in the presence of antibiotic ai . This fitness is 
a growth rate, so we are here using the letter f  for a quantity often denoted by α.  
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One-Way Analysis of Variance (ANOVA) was then used to compare the means 
of the growth rates obtained, and to determine if there were significant 
differences between the growth rates of adjacent genotypes.  
 
Derivation of Correlated Probability Model (CPM) 
Once the growth rates have been determined under various experimental 
conditions, the next step is to use them to compute fixation probabilities.  
 
If the (multiplicative) absolute fitnesses Wu  and Wv  of two neighboring genotypes 
u and v, differ by a small quantity then the (additive) relative fitness ln WuWv
⎛
⎝⎜
⎞
⎠⎟
  
can be approximated by  
 
 
1) ln WvWu
⎛
⎝⎜
⎞
⎠⎟
= T fv − fu( )  
where T  is the generation time.   Using a Taylor series approximation, 
 
2) ln WvWu
⎛
⎝⎜
⎞
⎠⎟
≈ WvWu
−1 .  
If Wv >Wu  , then 
3) pu ,v =
fv − fu
fuj − fu( )∑   
is the probability for v  to substitute u , where uj  are the neighbors of u  with 
higher fitness than u [19]. 
 
-Derivation of Equal Probability Model (EPM):  
According to the EPM model, the probabilities are equal for all beneficial 
mutations, so that one needs the fitness graphs only for computing the 
probabilities. The matrix entry M ( f )u ,v  is 1/ N  if genotype u  has N  outgoing 
arrows and there is an arrow from u  to v . 
 
CPM is accurate if fitness differences between genotypes are small, while EPM 
may provide better estimates if fitness differences are substantial. Indeed, if the 
fitness effects of all available beneficial mutants exceed some threshold, then 
fixation probabilities are independent of fitness values [23].  We applied both 
CPM and EPM, since no complete theory for substitution probabilities exists.  
Additionally, comparison of two models is useful in learning how sensitive our 
results are for variation in substitution probabilities. 
 
Time Machine Programs 
10	  
-Optimal antibiotic sequences and pathways of genotypes 
Let M[d]  denote the 16 ×16  transition matrix we derived for the antibiotic labeled 
a . For any sequence a1,a2,...ak  of k  antibiotics, we consider the matrix product 
M[a1]M[a2 ]...M[ak ] . This product is also a 16 ×16  transition matrix. Its entry in 
row u and column v is the fixation probability of genotype u  mutating to genotype 
v  under the antibiotic sequence a1,a2,...ak . That probability is a sum of products 
of entries in the individual matrices M f ai( )( ) , with one sum for each possible 
pathway of genotypes from u  to v . The Time Machine enumerates all 15k  
antibiotic sequences of length k , and it selects all sequences that maximize the 
entry in row u and column v of the matrix product. In a subsequent step we then 
analyze these optimal antibiotic sequences, and for each such sequence, we 
extract the full list of genotype pathways that contribute. 
 
We implemented this algorithm in the computer algebra software Maple, and we 
ran it for k = 2,3,4,5,6 . The running time of the program is slow because of the 
exponential growth in the number of sequences. At present we do not know 
whether an efficient algorithm exists for solving our optimization problem for 
larger values of k . 
 
-Cycles of antibiotics 
We also used this method to compute cyclical treatment paths in which the 
starting and ending genotypes were the wild type 0000.  The optimization 
problem we solved was somewhat different from the previous one, in that we 
focused on obtaining the maximal probabilities of a cycle that includes some 
substitutions and then returns to the wild type without halting. Halting means that 
adjacent genotypes in a mutational pathway coincide, which is undesirable. 
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 Figure Legends 
Figures 1-15 
These figures present a visual summary of the adaptive landscape 2x2x2x2 
tensors in which each resistance phenotype conferred by each TEM genotype is 
enumerated. Arrows pointing upward represent addition of a mutation. Arrows 
pointing downward represent reversions. Red arrows indicate significance 
between adjacent growth rates as determined by one way ANOVA. Genotypes 
that confer the most resistance to each antibiotic are shown in red.  
 
Figure 16 
Summary of CPM Substitutions with the Highest Probabilities. Each arrow is 
labeled by the drug or drugs corresponding to the maximal transition probability, 
taken over all 15 drugs. Each arrow is also labeled by the maximal probability. 
 
From the graph, it is possible to find candidate treatment plans. For example, 
when starting at genotype 1010 the graph shows that the probability for ending at 
0000 is 0.71for the sequence ZOX-TZP (0.71 is the product of the arrow labels). 
Similarly, when starting at 1111 the probability for ending at 0000 is 0.62 for the 
sequence CEC-CAZ-TZP-AM. When starting at 0001 the graphs shows that a 
single drug gives probability at most 0.29, whereas the probability for ending at 
0000 for the sequence AMC-CRO-AM (one arrow up, two arrows down) is at 
least.  
 
This graph can also be used to generate treatment paths that start and end at the 
same genotype, making possible the development of a fixed treatment plan.  For 
example, from a starting point 0000, the probability for ending at 0000 is 0.62 for 
the sequence: CEC-CTX-ZOX-CPD-CPR-CAZ-TZP-AM 
 
Figure 17 
Summary of Optimal 6 Step CPM and EPM Treatment Paths. Black arrows show 
transitions present in six step paths computed using both the CPM and the EPM. 
Red arrows signify transitions found only in optimum paths computed using the 
CPM whereas blue signify transitions only found using the EPM. 
 
Figure 18 
Summary of Optimal CPM 2, 4, and 6 Step Antibiotic Cycles.  Two step cycles 
are shown in red.  Four and six step cycles are shown in blue.  Four and six step 
cycles differ only in the number of substitutions and reversions that occur within 
each cycle. Their probabilities are identical.  
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Table 1 
Number of 
amino acid 
substitutions 
Number of 
identified 
TEM 
genotypes 
1 53 
2 53 
3 37 
4 31 
5 10 
6 2 
7 2 
8 0 
9 0 
10 1 
11 1 
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Table 2 Variant Genotypes Created, Binary Codes, Substitutions and 
(Names of Genotypes Identified in Clinical Isolates) 
Number of 
Substitutions 
Binary  
Genotype 
Code  
Genotypes with substitutions found in 
TEM-50  
0 0000 No substitutions, (TEM-1) 
1 1000 M69L, (TEM-33) 
1 0100 E104K, (TEM-17) 
1 0010 G238S, (TEM-19) 
1 0001 N276D, (TEM-84) 
2 1100 M69L, E104K, (Not identified) 
2 1010 M69L, G238S, (Not identified) 
2 1001 M69L, N276D, (TEM-35) 
2 0110 E104K, G238S, (TEM-15) 
2 0101 E104K, N276D, (Not identified) 
2 0011 G238S, N276D, (Not identified) 
3 1110 M69L, E104K, G238S, (Not identified) 
3 1101 M69L, E104K, N276D, (Not Identified) 
3 1011 M69L, G238S, N276D, (Not identified) 
3 0111 E104K, G238S, N276D, (Not identified) 
4 1111 M69L, E104K, G238S, N276D, (TEM-50) 
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Table 3 β-lactam Antibiotics used for this study 
 
β-lactam Antibiotic FDA approval Antibiotic Group 
Ampicillin (AMP) 1963 Aminopenicillin 
Amoxicillin (AM) 1972 Aminopenicillin 
Cefaclor (CEC) 1979 Cephalosporin 
Cefotaxime (CTX) 1981 Cephalosporin 
Ceftizoxime (ZOX) 1983 Cephalosporin 
Cefuroxime (CXM) 1983 Cephalosporin 
Ceftriaxone (CRO) 1984 Cephalosporin 
Amoxicillin + Clavulanic acid (AMC) 1984 Penicillin derivative + β-Lactamase inhibitor 
Ceftazidime (CAZ) 1985 Cephalosporin 
Cefotetan (CTT) 1985 Cephalosporin 
Ampicillin + Sulbactam (SAM) 1986 Penicillin derivative + β-Lactamase inhibitor 
Cefprozil (CPR) 1991 Cephalosporin 
Cefpodoxime (CPD) 1992 Cephalosporin 
Pipercillin + Tazobactam (TZP) 1993 Penicillin derivative + β-Lactamase inhibitor 
Cefepime (FEP) 1996 Cephalosporin 
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Table 4 Average Growth Rates ( x 10-3): the rows are the fitness landscapes 
 
 
0000 1000 0100 0010 0001 1100 1010 1001 
AMP 1.851 1.570 2.024 1.948 2.082 2.186 0.051 2.165 
AM 1.778 1.720 1.448 2.042 1.782 1.557 1.799 2.008 
CEC	   2.258 0.234 2.396 2.151 1.996 2.150 2.242 0.172 
CTX 0.160 0.185 1.653 1.936 0.085 0.225 1.969 0.140 
ZOX 0.993 1.106 1.698 2.069 0.805 1.116 1.894 1.171 
CXM 1.748 0.423 2.940 2.070 1.700 2.024 1.911 1.578 
CRO 1.092 0.830 2.880 2.554 0.287 1.407 3.173 0.540 
AMC 1.435 1.417 1.672 1.061 1.573 1.377 1.538 1.351 
CAZ 2.134 0.288 2.042 2.618 2.656 2.630 1.604 0.576 
CTT 2.125 3.238 3.291 2.804 1.922 0.546 2.883 2.966 
SAM 1.879 2.198 2.456 0.133 2.533 2.504 2.308 2.570 
CPR 1.743 1.553 2.018 1.763 1.662 0.223 0.165 0.256 
CPD 0.595 0.432 1.761 2.604 0.245 0.638 2.651 0.388 
TZP 2.679 2.709 3.038 2.427 2.906 2.453 0.172 2.500 
FEP 2.590 2.067 2.440 2.393 2.572 2.735 2.957 2.446 
 
0110 0101 0011 1110 1101 1011 0111 1111 
AMP 2.033 2.198 2.434 0.088 2.322 0.083 0.034 2.821 
AM 1.184 1.544 1.752 1.768 2.247 2.005 0.063 2.047 
CEC	   2.230 1.846 2.648 2.640 0.095 0.093 0.214 0.516 
CTX 2.295 0.138 2.348 0.119 0.092 0.203 2.269 2.412 
ZOX 2.138 2.010 2.683 1.103 1.105 0.681 2.688 2.591 
CXM 2.918 2.173 1.938 1.591 1.678 2.754 3.272 2.923 
CRO 2.732 0.656 3.042 2.740 0.751 1.153 0.436 3.227 
AMC 0.073 1.625 1.457 1.307 1.914 1.590 0.068 1.728 
CAZ 2.924 2.756 2.688 2.893 2.677 1.378 0.251 2.563 
CTT 3.082 2.888 0.588 3.193 3.181 0.890 3.508 2.543 
SAM 0.083 2.437 0.094 2.528 3.002 2.886 0.094 3.453 
CPR 2.042 2.050 1.785 1.811 0.239 0.221 0.218 0.288 
CPD 2.910 1.471 3.043 0.963 0.986 1.103 3.096 3.268 
TZP 2.528 3.309 0.141 0.609 2.739 0.093 0.143 0.171 
FEP 2.652 2.808 2.832 2.796 2.863 2.633 0.611 3.203 
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Table 5 Rank Order of Genotypes in Each β-Lactam Antibiotic (Derived 
From Table 4) 
 
  
Antibiotic 0000 1000 0100 0010 0001 1100 1010 1001 0110 0101 0011 1110 1101 1011 0111 1111 
AMP 11 12 9 10 7 5 15 6 8 4 2 13 3 14 16 1 
AM 8 11 14 3 7 12 6 4 15 13 10 9 1 5 16 2 
CEC 4 12 3 7 9 8 5 14 6 10 1 2 15 16 13 11 
CTX 11 10 7 6 16 8 5 12 3 13 2 14 15 9 4 1 
ZOX 14 11 8 5 15 10 7 9 4 6 2 3 12 16 1 3 
CXM 11 16 2 7 12 8 10 15 4 6 9 14 13 5 1 3 
CRO 10 11 4 7 16 8 2 14 6 13 3 5 12 9 15 1 
AMC 9 10 3 14 6 11 7 12 15 4 8 13 1 5 16 2 
CAZ 10 15 11 8 6 7 12 14 1 3 4 2 5 13 16 9 
CTT 12 3 2 10 13 16 9 7 6 8 15 4 5 14 1 11 
SAM 12 11 8 13 5 7 10 4 16 9 14 6 2 3 15 1 
CPR 7 9 3 6 8 13 16 11 2 1 5 4 12 14 15 10 
CPD 13 14 7 6 16 12 5 15 4 8 3 11 10 9 2 1 
TZP 6 5 2 10 3 9 12 8 7 1 15 11 4 16 14 13 
FEP 10 15 13 14 11 7 2 12 8 5 4 6 3 9 16 1 
Best 
value 4 3 2 3 3 5 2 4 1 1 1 2 1 3 1 1 
Worst 
value 14 16 14 14 16 16 15 15 16 13 15 14 15 16 16 13 
Median 
value 10 11 7 7 9 8 7 12 6 6 4 6 5 9 15 2 
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Table 6. Maximum Probability and Number of Paths Using CPM 
Starting 
Genotype 
1 
Step No. 
of 
paths 
2 
Step No. 
of 
paths 
3 
Step No. 
of 
paths 
4 
Step No. 
of 
paths 
5 
Step No. 
of 
paths 
6 
Step No. 
of 
paths 
1000 1.0 1 1.0 3 1.0 7 1.0 15 1.0 31 1.0 63 
0100 0.617 1 0.617 6 0.617 36 0.617 219 0.617 1360 0.617 8568 
0010 0.715 1 0.715 2 0.715 3 0.715 4 0.715 5 0.715 6 
0001 0.287 1 0.287 1 0.592 2 0.592 8 0.726 2 0.726 4 
1100 
- 
 0.617 3 0.617 18 0.617 108 0.617 657 0.617 4110 
1010 
- 
 0.715 1 0.715 6 0.715 27 0.715 112 0.715 453 
1001 
- 
 0.559 1 0.559 4 0.726 1 0.726 2 0.729 1 
0110 
- 
 0.617 1 0.617 10 0.617 78 0.617 555 0.617 3805 
0101 
- 
 0.592 1 0.592 9 0.612 1 0.612 9 0.617 34 
0011 
- 
 0.361 1 0.361 9 0.586 2 0.600 2 0.617 8 
1110 
- 
 -  0.617 2 0.617 24 0.617 215 0.617 1720 
1101 
- 
 -  0.592 2 0.592 24 0.617 12 0.617 252 
1011 
- 
 -  0.532 1 0.532 1 0.684 1 0.690 1 
0111 
- 
 -  0.586 1 0.600 1 0.617 4 0.617 84 
1111 
- 
 -  - - 0.617 4 0.617 72 0.617 906 
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Table 7. Maximum Probability and Number of Paths Using EPM 
Starting 
Genotype 
1 
Step 
No. of 
paths 
2 
Step 
No. of 
paths 
3 
Step 
No. of 
paths 
4 
Step No. of 
paths 
5 
Step 
No. of 
paths 
6 
Step 
No. of 
paths 
1000 1.0 1 1.0 3 1.0 7 1.0 15 1.0 31 1.0 63 
0100 
0.33 
1 
0.33 
6 
0.33 
39 
0.38 
1 
0.46 
1 0.46 9 
0010 
0.50 
1 
0.50 
4 
0.50 
6 
0.50 
8 
0.50 
10 0.50 12 
0001 
0.50 
1 
0.50 
1 
0.66 
4 
0.66 
8 
0.66 
14 0.66 24 
1100 
- 
 
0.33 
27 
0.39 
1 
0.39 
1 
0.39 
4 0.46 5 
1010 
- 
 
0.50 
3 
0.50 
19 
0.58 
1 
0.58 
8 0.59 1 
1001 
- 
 
0.66 
2 
0.66 
4 
0.66 
7 
0.66 
12 0.69 1 
0110 
- 
 
0.33 
1 
0.33 
10 
0.33 
81 
0.38 
1 0.46 1 
0101 
- 
 
0.29 
1 
0.38 
1 
0.46 
1 
0.46 
4 046 1 
0011 
- 
 
0.25 
4 
0.25 
32 
0.50 
2 
0.50 
18 0.50 133 
1110 
- 
 -  
0.33 
2 
0.33 
24 
0.33 
221 0.38 6 
1101 
- 
 -  
0.29 
2 
0.38 
2 
0.46 
2 0.46 14 
1011 
- 
 -  
0.33 
3 
0.33 
8 
0.39 
1 0.52 1 
0111 
- 
 -  
0.15 
1 
0.20 
8 
0.33 
4 0.38 6 
1111 
- 
 -  - - 
0.33 
4 
0.38 
4 0.46 4 
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Table 8. CPM Additions of Substitutions And Associated β-lactam 
Antibiotics From Optimal Six Step Treatment Plans  (*Maximum Probability 
for Path) 
Mutations 
Drugs associated with substitutions in 
optimal paths (probability) 
0000-1000 CTT(0.38*) 
0000-0100  
0000-0010  
0000-0001  
1000-1100  
1000-1010  
1000-1001  
0100-1100 SAM(1.0*) 
0100-0110 CTX(1.0*), CPD(1.0*) 
0100-0101  
0010-1010 CTT(0.22) 
0010-0110  
0010-0011  
0001-1001 AM(1.0*), CTT(0.47), SAM(1.0*) 
0001-0101  
0001-0011  
1100-1110 CAZ(0.85*), SAM(0.046), FEP(0.32) 
1100-1101 
AMP(1.0*),CAZ(0.15), SAM(0.95), 
FEP(0.68) 
1010-1110 CEC(1.0*), CTT(0.47) 
1010-1011  
1001-1101  
1001-1011 CTX(0.50*) 
0110-1110 FEP(1.0*) 
0110-0111 ZOX(1.0*), CXM(0.94), CPD(1.0*) 
0101-1101 AMP(1.0*), FEP(1.0*) 
0101-0111 
CTX(0.58), ZOX(1.0*), CXM(0.59), 
CPD(0.85) 
0011-1011 CTT(0.04) 
0011-0111 ZOX(1.0*), CPD(1.0*)  
1110-1111 
AM(0.90), CRO(0.53), SAM(1.0*), 
CPD(0.39), FEP(0.72) 
1101-1111 AMP(1.0*), SAM(1.0*), FEP(1.0*) 
1011-1111 TZP(0.03) 
0111-1111 CPD(1.0*) 
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Table 9. CPM Reversions of Substitutions And Associated β-lactam 
Antibiotics From Optimal Six Step Treatment Plans  (*Maximum Probability 
for Path) 
Reversions 
Drugs associated with substitutions in 
optimal paths (probability) 
1111-1110 
CEC(1.0*), CAZ(0.74), CTT(0.29), CPR(1.0*), 
TZP(0.15)  
1111-1101 AM(1.0*), AMC(1.0*), CAZ(0.26), TZP(0.85) 
1111-1011  
1111-0111 ZOX(1.0*), CXM(1.0*) 
1110-1100 TZP(0.49*) 
1110-1010 AM(0.10), CRO(0.47*), CPD(0.28), FEP(0.28) 
1110-0110 CAZ(1.0*), CPR(1.0*), CPD(0.33), TZP(0.51) 
1101-1100  
1101-1001  
1101-0101  
1011-1010 TZP(0.30) 
1011-1001 TZP(0.92*) 
1011-0011 TZP(0.18) 
0111-0110  
0111-0101  
0111-0011  
1100-1000 CTT(0.25) 
1100-0100 CTX(1.0*), ZOX(1.0*), CXM(1.0*) 
1010-1000 CTT(0.53*), TZP(0.49) 
1010-0010 ZOX(1.0*), TZP(0.43) 
1001-1000 CTX(0.42), CTT(0.56) 
1001-0001  
0110-0100 CXM(0.58), TZP(1.0*) 
0110-0010  
0101-0100 CTX(0.42), CXM(0.41), CPD(0.15) 
0101-0001  
0011-0010 CTT(0.33), TZP(0.45) 
0011-0001 CTT(0.20), TZP(0.55) 
1000-0000 CPR(1.0*) 
0100-0000 AM(0.62*) 
0010-0000 TZP(0.71*) 
0001-0000 CTT(0.092), CPR(0.14) 
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Table 10. EPM Additions of Substitutions and Associated β-lactam 
Antibiotics From Optimal Six Step Treatment Plans 
 
Mutations 
β-lactams associated 
with substitutions in 
optimal paths 
(probability) 
0000-1000  
0000-0100  
0000-0010  
0000-0001 
 
 
1000-1100  
1000-1010  
1000-1001  
0100-1100 SAM(1.0*) 
0100-0110  
0100-0101 TZP(1.0*) 
0010-1010  
0010-0110  
0010-0011  
0001-1001 AM(1.0*), SAM(1.0*) 
0001-0101 TZP(1.0*) 
0001-0011  
1100-1110 CTT(1/4) 
1100-1101 AMP(1.0*), CPR(1/4) 
1010-1110 CTT(1/2) 
1010-1011  
1001-1101  
1001-1011 CTX(1/2*) 
0110-1110  CTT(1/3) 
0110-0111  
0101-1101 AM(1/2), AMC(1/2) 
0101-0111  
0011-1011 AMC(1/2*) 
0011-0111  
1110-1111 SAM(1.0*) 
1101-1111  
1011-1111 CTT(1/3) 
0111-1111 SAM(1/2), CPD(1.0*) 
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Table 11. EPM Reversions of Substitutions and Associated β-lactam 
Antibiotics From Optimal Six Step Treatment Plans 
 
Reversions 
β-lactams associated with substitutions in optimal 
paths (probability) 
1111-1110 CTT(1/3) 
1111-1101 AM(1.0*) , AMC(1.0*) 
1111-1011  
1111-0111  
1110-1100 TZP(1/2*) 
1110-1010  
1110-0110 CAZ(1.0*), CPR(1.0*), TZP(1/2) 
1101-1100  
1101-1001 CPR(1/3*) 
1101-0101 CAZ(1.0*), TZP(1.0*) 
1011-1010 CTT(1/3*) 
1011-1001 AM(1/2*), CTT(1/3) 
1011-0011  
0111-0110  
0111-0101 SAM(1/2*) 
0111-0011  
1100-1000 CTT(1/4), CPR(1/4), TZP(1/3*) 
1100-0100 CTX(1.0*), ZOX(1.0*), CXM(1.0*) 
1010-1000 CTT(1/2*), TZP(1/3) 
1010-0010  
1001-1000 CEC(1/2*), CTX(1/2*), CTT(1/2*), CPR(1/2*), TZP(1/3) 
1001-0001 CEC(1/2*), CPR(1/2*) 
0110-0100 TZP(1.0*) 
0110-0010  
0101-0100 CEC(1/2*), AMC(1/2*) 
0101-0001 AM(1/2*), CEC(1/2*) 
0011-0010  
0011-0001 AMC(1/2*) 
1000-0000 CPR(1.0*) 
0100-0000 FEP(1/4) 
0010-0000 SAM(1/2*), TZP(1/2*) 
0001-0000 CEC(1/2*), CPR(1/3), FEP(1/3) 
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Table 12:  Cyclical Treatment Paths showing Substitutions and Associated 
β-lactam Antibiotics 
 
Path length 
and 
probability 
(prob) 
0000-0010/ 
0010-0000 
0000-0100/ 
0100-0000 
0100-0110/ 
0110-0100 
0100-1100/ 
1100-0100 
2-step (0.70)     
Cycle 1 AM/TZP    
4-step (0.62)     
Cycle 2  CEC/AM CTX/TZP  
Cycle 3  CEC/AM  SAM/CTX 
Cycle 4  CEC/AM  SAM/ZOX 
Cycle 5  CEC/AM  SAM/CXM 
Cycle 6  CEC/AM CPD/TZP  
6-step (0.62)     
Cycle 7  CEC/AM CTX/TZP(2x)  
Cycle 8  CEC/AM CTX/TZP SAM/CTX 
Cycle 9  CEC/AM CTX/TZP SAM/ZOX 
Cycle 10  CEC/AM CTX/TZP SAM/CXM 
Cycle 11  CEC/AM CTX/TZP, 
CPD/TZP 
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Figure 1 AMP: Ampicillin 256 µg/ml 
 
 
Figure 2 AM: Amoxicillin 512 µg/ml
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1000 0100 0010 0001
1100 1010 1001 0110 0101 0011
1110 1101 1011 0111
1111
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Figure 3 CEC: Cefaclor 1 µg/ml 
 
Figure 4 CTX: Cefotaxime 0.05 µg/ml 
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Figure 5 ZOX: Ceftizoxime 0.03 µg/ml
 
 
Figure 6 CXM: Cefuroxime 1.5 µg/ml
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Figure 7 CRO: Ceftriaxone 0.045 µg/ml
 
 
Figure 8 AMC: Amoxicillin/Clavulanate 512 µg/ml and 8µg/ml 
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Figure 9 CAZ: Cefazidime 0.1 µg/ml 
 
 
Figure 10 CTT: Cefotetan 0.312 µg/ml 
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Figure 11 SAM: Ampicillin/Sulbactam 8 µg/ml and 8µg/ml
 
 
Figure 12 CPR: Cefprozil 100 µg/ml 
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Figure 13 CPD: Cefpodoxime 2 µg/ml 
 
 
 
Figure 14 TZP: Pipercillin / Tazobactam 8.12µg/ml and 8 µg.ml 
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Figure 15 FEP: Cefepime 0.0156µg/ml 
 
 0000
1000 0100 0010 0001
1100 1010 1001 0110 0101 0011
1110 1101 1011 0111
1111
34	  
 Figure 16: Summary of Highest CPM probabilities 
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Figure 17. Summary of Optimal Six Step Sequences (EPM and CPM) 
 
 
 
Figure 18. Summary of Optimized Two, Four, and Six Step CPM Antibiotic 
Cycles 
 
 
 
0000
1000 0100 0010 0001
1100 1010 1001 0110 0101 0011
1110 1101 1011 0111
1111
0000
1000 0100 0010 0001
1100 1010 1001 0110 0101 0011
1110 1101 1011 0111
1111
TZ
P
AM
CEC
CT
X/C
PD
TZ
P
AM
SAM
CTX/ZOX/CXM
Supporting Information                            
For any biallelic system and set of drugs, the 
maximum probabilities for returning to the 
wild-type depend on how many steps one allows 
in the treatment plan. The following example 
demonstrates that the maximum probabilities 
may increase by the number of steps 
indefinitely.
Consider a three-loci system where the 
genotypes are ordered as:
000, 100, 010, 001, 110, 101, 011, 111. 
Asume that the starting point is the genotype 
100 and that Drugs A and B (see below) are 
available. For the sequence A, the probability 
for ending at 000 is 0.9, for A-B-A  0.99, for
A-B-A-B-A 0.999, and so forth.
 1   0   0 0 0   0   0   0  
 0.9 0   0 0 0.1 0   0   0  
 1/3 0   0 0 1/3 0   1/3 0  
 1/3 0   0 0 0   1/3 1/3 0  
 0   0   0 0 0   0   0   1  
 0   1/2 0 0 0   0   0   1/2
 0   0   0 0 0   0   0   1  
 0   0   0 0 0   0   0   1  
                        
 1   0 0 0 0   0   0   0
 1/2 0 0 0 0   1/2 0   0
 1/3 0 0 0 1/3 0   1/3 0
 1/3 0 0 0 0   1/3 1/3 0
 0   1 0 0 0   0   0   0
 0   0 0 0 0   1   0   0
 0   0 0 0 0   0   0   1
 0   0 0 0 1/2 1/2 0   0
interface(quiet=true):
with(linalg): die := rand(0..10000):
alleins := transpose(array([[1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1]])):
antibiotics := [AMP,AM,CEC,CTX,ZOX,CXM,CRO,
AMC,CAZ,CTT,SAM,CPR,CPD,TZP,FEP]:
labels2 := [
[0,0,0,0],[1,0,0,0],[0,1,0,0],[0,0,1,0],
[0,0,0,1],[1,1,0,0],[1,0,1,0],[1,0,0,1],
[0,1,1,0],[0,1,0,1],[0,0,1,1],[1,1,1,0],
[1,1,0,1],[1,0,1,1],[0,1,1,1],[1,1,1,1]]:
Data := 
[[0.001850833,0.001570000,0.002024167,0.001948333,0.002081667,0.002185
833,0.000050800,0.002165000,0.002032500,0.002197500,0.002434167,0.0000
87500,0.002321667,0.000082500,0.000034200,0.002820833],
[0.001777500,0.001720000,0.001448333,0.002041667,0.001781667,0.0015566
67,0.001799167,0.002008333,0.001184167,0.001544167,0.001751667,0.00176
7500,0.002246667,0.002005000,0.000062500,0.002046667],
[0.002258333,0.000234167,0.002395833,0.002150833,0.001995833,0.0021500
00,0.002241667,0.000171667,0.002230000,0.001845833,0.002647500,0.00264
0000,0.000095000,0.000093300,0.000214167,0.000515833],
[0.000160000,0.000185000,0.001653333,0.001935833,0.000085000,0.0002250
00,0.001969167,0.000140000,0.002295000,0.000137500,0.002347500,0.00011
9167,0.000091700,0.000203333,0.002269167,0.002411667],
[0.000993333,0.001105833,0.001697500,0.002069167,0.000805000,0.0011158
33,0.001894167,0.001170833,0.002137500,0.002010000,0.002682500,0.00110
3333,0.001105000,0.000680833,0.002688333,0.002590833],
[0.001747500,0.000422500,0.002940000,0.002070000,0.001700000,0.0020241
67,0.001910833,0.001578333,0.002918333,0.002173333,0.001937500,0.00159
0833,0.001677500,0.002754167,0.003271667,0.002923333],
[0.001091667,0.000830000,0.002880000,0.002554167,0.000286667,0.0014066
67,0.003172500,0.000540000,0.002731667,0.000655833,0.003041667,0.00274
0000,0.000750833,0.001152500,0.000435833,0.003226667],
[0.001435000,0.001416667,0.001671667,0.001060833,0.001573333,0.0013766
67,0.001537500,0.001350833,0.000073300,0.001625000,0.001456667,0.00130
6667,0.001914167,0.001590000,0.000067500,0.001727500],
[0.002134167,0.000288333,0.002041667,0.002618333,0.002655833,0.0026300
00,0.001604167,0.000575833,0.002924167,0.002755833,0.002687500,0.00289
3333,0.002676667,0.001378333,0.000250833,0.002562500],
[0.002125000,0.003238333,0.003290833,0.002804167,0.001921667,0.0005458
33,0.002882500,0.002965833,0.003081667,0.002887500,0.000587500,0.00319
2500,0.003180833,0.000890000,0.003507500,0.002543333],
[0.001879167,0.002197500,0.002455833,0.000133333,0.002532500,0.0025041
67,0.002308333,0.002570000,0.000083300,0.002436667,0.000094200,0.00252
8333,0.003001667,0.002885833,0.000094200,0.003453333],
[0.001743333,0.001553333,0.002017500,0.001762500,0.001661667,0.0002225
00,0.000165000,0.000255833,0.002041667,0.002050000,0.001785000,0.00181
0833,0.000239167,0.000220833,0.000217500,0.000288333],
[0.000595000,0.000431667,0.001760833,0.002604167,0.000245000,0.0006375
00,0.002650833,0.000388333,0.002910000,0.001470833,0.003042500,0.00096
2500,0.000985833,0.001102500,0.003095833,0.003268333],
[0.002679167,0.002709167,0.003037500,0.002426667,0.002905833,0.0024533
33,0.000171667,0.002500000,0.002527500,0.003309167,0.000140833,0.00060
9167,0.002739167,0.000093300,0.000142500,0.000170833],
[0.002590000,0.002066667,0.002440000,0.002393333,0.002571667,0.0027350
00,0.002956667,0.002445833,0.002651667,0.002807500,0.002831667,0.00279
5833,0.002863333,0.002632500,0.000610833,0.003202500]]:
lprint(labels2);
cubegraph := {}:
for i from 1 to 16 do
for j from 1 to 16 do
agree := 0:
for k from 1 to 4 do
if (labels2[i][k] = labels2[j][k]) then agree := agree+1: fi:
od:
if (agree = 3) then cubegraph := cubegraph union {{i,j}}: fi:
od:od:
for i from 1 to 15 do
F := []:
for j from 1 to 16 do F := [F[],die()]: od:
Data := [Data[],F]:
od:
T := []:
for antibiotic from 1 to 15 do
print(antibiotic);
fitness := Data[antibiotic];
#lprint(fitness);
outdeg := []: allcount := 0:
for i from 1 to 16 do
count := 0:
for j from 1 to 16 do
if ((member({i,j},cubegraph)) and (fitness[i] < fitness[j])) then
# NEW
  count := count+fitness[j]-fitness[i]:
fi:
od:
allcount := allcount+count:
outdeg := [outdeg[],count]:
od:
M := []:
for i from 1 to 16 do
M := [M[],[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]]:
od:
for i from 1 to 16 do
if (outdeg[i] = 0) then M[i][i] := 1:
else
 for j from 1 to 16 do 
 if ((member({i,j},cubegraph)) and (fitness[i] < fitness[j])) then
# NEW
 M[i][j] := (fitness[j]-fitness[i])/outdeg[i]:
# M[i][j] := 1/outdeg[i]:
 fi:
 od:
fi:
od:
T := [T[],M]:
for k from 1 to 16 do lprint(M[k],`,`); od:
od:
quit
> ## Transition matrices for the fitness landscapes of the 15 drugs
> ## computed with "Method 2" in Kristina's write-up of March 9.
> 
> interface(quiet=true):
> with(linalg): with(combinat):
> 
> an := [ AMP,AM,CEC,CTX,ZOX,CXM,CRO,AMC,CAZ,CTT,SAM,CPR,CPD,TZP,FEP]:
> 
> labels2 := [
> [0,0,0,0],[1,0,0,0],[0,1,0,0],[0,0,1,0],
> [0,0,0,1],[1,1,0,0],[1,0,1,0],[1,0,0,1],
> [0,1,1,0],[0,1,0,1],[0,0,1,1],[1,1,1,0],
> [1,1,0,1],[1,0,1,1],[0,1,1,1],[1,1,1,1]]:
> 
> M1 := array([
> [0, 0, .3455153608, .1943516429, .4601329963, 0, 0, 0, 0, 0, 0, 0, 
0, 0, 0,
> 0],
> [.1882680171, 0, 0, 0, 0, .4128491231, 0, .3988828598, 0, 0, 0, 0, 
0, 0, 0,
> 0],
> [0, 0, 0, 0, 0, .4708736733, 0, 0, .2427096804e-1, .5048553587, 0, 
0, 0, 0,
> 0,0],
> [0, 0, 0, 0, 0, 0, 0, 0, .1476611445, 0, .8523388555, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, .1510569801, 0, .2099694380, .6389735818, 0, 
0, 0, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0],
> [0, .4359087587, 0, .5444650175, 0, 0, 0, 0, 0, 0, 0, .
1053044461e-1, 0,
> .9095779128e-2, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, .3096409060, 0, 0, .2870142929, 0, 0, 0, 0, 0, 0,
> .4033448011],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, 0, .2903450680, 0, 0, .3278727083, 0, 0, 0, 0,
> .3817822238],
> [0, 0, 0, 0, 0, 0, 0, 0, .2137630774, .2314135342, .2567303866, 0, 
0, 0, 0,
> .2980930019],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]]):
> 
> 
> M2 := array([
> [0, 0, 0, .9844708460, .1552915396e-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [.1352941176, 0, 0, 0, 0, 0, .1862752941, .6784305882, 0, 0, 0, 0, 
0, 0, 0,
> 0],
> [.6171861963, 0, 0, 0, 0, .2031256152, 0, 0, 0, .1796881885, 0, 0, 
0, 0, 0,
> 0],
> [0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, .1534845128, 0, 0, 0, 0, 0, 0, 0, 0, 0, .1981204060, .
6483950812, 0, 0,
> 0],
> [0, 0, 0, .5408925955, 0, 0, 0, 0, 0, 0, 0, 0, 0, .4591074045, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0],
> [0, 0, .1549361613, .5029328463, 0, 0, 0, 0, 0, 0, 0, .3421309925, 
0, 0, 0,
> 0],
> [0, 0, 0, 0, .2526595745, 0, 0, 0, 0, 0, 0, 0, .7473404255, 0, 0, 
0],
> [0, 0, 0, .5058142476, .5232561182e-1, 0, 0, 0, 0, 0, 0, 0, 0, .
4418601406,
> 0,0],
> [0, 0, 0, 0, 0, 0, .1018775295, 0, 0, 0, 0, 0, 0, 0, 0, .
8981224705],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, .7406666667e-1, 0, 0, 0, 0, 0, 0, 0, .
9259333333],
> [0, 0, 0, 0, 0, 0, 0, 0, .1787042106, .2360594825, .2691184240, 0, 
0, 0, 0,
> .3161178829],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0]]):
> 
> M3 := array([
> [0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [.3403390232, 0, 0, 0, 0, .3221241399, .3375368369, 0, 0, 0, 0, 0, 
0, 0, 0,
> 0],
> [0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [.1388587490, 0, 0, 0, 0, 0, .1173311219, 0, .1022607496, 0, .
6415493795, 0,
> 0,0, 0, 0],
> [.2871466592, 0, 0, 0, 0, 0, 0, 0, 0, 0, .7128533408, 0, 0, 0, 0, 
0],
> [0, 0, .3340880336, 0, 0, 0, 0, 0, 0, 0, 0, .6659119664, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0],
> [0, .3312722019e-1, 0, 0, .9668727798, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, .2879880104, 0, 0, 0, 0, 0, 0, 0, 0, .7120119896, 0, 0, 0, 
0],
> [0, 0, .7857142857, 0, .2142857143, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, .4775368302, 0, .1781572562e-1, 0, .4068551051, 0, 
0, 0, 0,
> 0,.9779233910e-1],
> [0, 0, 0, 0, 0, 0, .4128722254, .1506053560e-1, 0, 0, .4908650329, 
0, 0, 0,
> 0,.8120220614e-1],
> [0, 0, 0, 0, 0, 0, 0, 0, .3158376234, .2556469270, .3812508833, 0, 
0, 0, 0,
> .4726456632e-1],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0]]):
> 
> M4 := array([
> [0, .7589174316e-2, .4533265780, .5390842477, 0, 0, 0, 0, 0, 0, 0, 
0, 0, 0,
> 0,0],
> [0, 0, 0, 0, 0, .2192781692e-1, .9780721831, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .4145153749e-1, 0, .4466317983, 0, .5119166642, 
0, 0, 0,
> 0,0],
> [.3067484663e-1, 0, 0, 0, 0, 0, 0, .2249488753e-1, 0, .
2147239264e-1,
> .9253578732, 0, 0, 0, 0, 0],
> [0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, .4153858935, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .5846141065, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, .4155813571, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .5844186429, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, .1647420070e-1, .2879751239, 0, .3386950150, 0, 0, 
0, 0, 0, 0,
> .3568556603],
> [0, 0, 0, 0, 0, .5232854159e-1, 0, .1896075438e-1, 0, .
1797934887e-1, 0, 0, 0,
> 0, 0, .9107313552],
> [0, 0, 0, 0, 0, 0, .2886134872, 0, 0, 0, .3504494278, 0, 0, 0, 0,
> .3609370850],
> [0, 0, 0, 0, 0, 0, 0, 0, .1047286614, 0, .3175670745, 0, 0, 0, 0,
> .5777042641],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]]):
> 
> M5 := array([
> [0, .5944514692e-1, .3720827624, .5684720906, 0, 0, 0, 0, 0, 0, 0, 
0, 0, 0, 0,
> 0],
> [0, 0, 0, 0, 0, .1158300264e-1, .9131274802, .7528951715e-1, 0, 0, 
0, 0, 0, 0,
> 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, .5847176080, .4152823920, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, .1002441078, 0, .8997558922, 0, 0, 0, 0, 
0],
> [.5178726889e-1, 0, 0, 0, 0, 0, 0, .1005957105, 0, .3313474485, .
5162695722,
> 0, 0, 0, 0, 0],
> [0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0],
> [0, 0, 0, 0, 0, .3759397366e-2, .2378447405, 0, .3110275756, 0, 0, 
0, 0, 0, 0,
> .4473682865],
> [0, 0, 0, 0, 0, .4390275335e-2, 0, .2668005134e-1, 0, .3667681324, 
0, 0, 0, 0,
> 0, .6021615409],
> [0, 0, 0, 0, 0, 0, .2160879401, .8726623557e-1, 0, 0, .3564855999, 
0, 0, 0, 0,
> .3401602244],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0]]):
> 
> M6 := array([
> [0, 0, .7871287129, .2128712871, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [.2378459379, 0, 0, 0, 0, .2875094263, .2671652516, .2074793841, 0, 
0, 0, 0,
> 0,0, 0, 0],
> [0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0],
> [.6263739017e-1, 0, 0, 0, 0, 0, 0, 0, 0, .6241756590, .3131869509, 
0, 0, 0,
> 0,0],
> [0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, .1587699164, 0, 0, 0, 0, 0, 0, 0, 0, 0, .8412300836, 0, 
0],
> [0, 0, 0, 0, .8711232734e-1, 0, 0, 0, 0, 0, 0, 0, .7100255752e-1,
> .8418851151,0, 0],
> [0, 0, .5777851259e-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .9422214874, 
0],
> [0, 0, .4110812809, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .5889187191, 
0],
> [0, 0, 0, .5802918014e-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, .3576642751,
> .5843065447,0],
> [0, 0, 0, 0, 0, .1269532955, .9374998169e-1, 0, .3889159397, 0, 0, 
0, 0, 0, 0,
> .3903807831],
> [0, 0, 0, 0, 0, .1660017823, 0, 0, 0, .2374300459, 0, 0, 0, 0, 0,
> .5965681718],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0]]):
> 
> M7 := array([
> [0, 0, .5501153089, .4498846911, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [.8226364532e-1, 0, 0, 0, 0, .1812942769, .7364420778, 0, 0, 0, 0, 
0, 0, 0,
> 0,0],
> [0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .4818180472, 0, .1383117242, 0, .3798702285, 0, 
0, 0, 0,
> 0],
> [.1924686653, 0, 0, 0, 0, 0, 0, .6056976941e-1, 0, .8826445625e-1,
> .6586971091,0, 0, 0, 0, 0],
> [0, 0, .5249406235, 0, 0, 0, 0, 0, 0, 0, 0, .4750593765, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, .2604791199, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .1893710148, .
5501498653, 0,
> 0],
> [0, 0, .9468104120, 0, 0, 0, 0, 0, 0, 0, 0, .5318958804e-1, 0, 0, 0, 
0],
> [0, 0, .9590370163, 0, 0, 0, 0, 0, 0, 0, 0, 0, .4096298369e-1, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .4705347342, 0, 0, 0, 0, 0, 0, 0, 0, .
5294652658],
> [0, 0, 0, 0, 0, .2094200279, 0, 0, 0, 0, 0, 0, 0, 0, 0, .
7905799721],
> [0, 0, 0, 0, 0, 0, .3376044192, 0, 0, 0, .3157381821, 0, 0, 0, 0,
> .3466573987],
> [0, 0, 0, 0, 0, 0, 0, 0, .2901527229, .2780410040e-1, .3293312280, 
0, 0, 0, 0,
> .3527119488],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]]):
> 
> 
> M8 := array([
> [0, 0, .6311120000, 0, .3688880000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [.1317347628, 0, 0, 0, 0, 0, .8682652372, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [.3001336362, 0, 0, 0, 0, 0, .3823527996, 0, 0, 0, .3175135642, 0, 
0, 0, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0],
> [0, .4584527221e-1, .3381088825, 0, 0, 0, 0, 0, 0, 0, 0, 0, .
6160458453, 0,
> 0,0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0],
> [0, .6035193224e-1, 0, 0, .2039721864, 0, 0, 0, 0, 0, 0, 0, .
5164245738,
> .2192513075, 0, 0],
> [0, 0, .4185009846, .2585661071, 0, 0, 0, 0, 0, 0, 0, .3229329083, 
0, 0, 0,
> 0],
> [0, 0, .1389585331, 0, 0, 0, 0, 0, 0, 0, 0, 0, .8610414669, 0, 0, 
0],
> [0, 0, 0, 0, .4666658667, 0, 0, 0, 0, 0, 0, 0, 0, .5333341333, 0, 
0],
> [0, 0, 0, 0, 0, .9699778014e-1, .3198612655, 0, 0, 0, 0, 0, 0, 0, 0,
> .5831409544],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, 0, 0, .1257461571e-2, .3376717926, .3011765721, 
0, 0, 0,
> 0,.3598941738],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0]]):
> 
> 
> M9 := array([
> [0, 0, 0, .4813587160, .5186412840, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [.3187509228, 0, 0, 0, 0, .4043746714, .2272269889, .4964741700e-1, 
0, 0, 0,
> 0,0, 0, 0, 0],
> [.4061472694e-1, 0, 0, 0, 0, .2583241529, 0, 0, .3874864490, .
3135746712, 0,
> 0,0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, .8155551585, 0, .1844448415, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, .7594917481, .2405082519, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .8494612903, .1505387097, 0, 0, 
0],
> [0, 0, 0, .4403038728, 0, 0, 0, 0, 0, 0, 0, .5596961272, 0, 0, 0, 
0],
> [0, 0, 0, 0, .4173912485, 0, 0, 0, 0, 0, 0, 0, .4215719837, .
1610367678, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .8305261021e-1, 0, 0, 0, .4814586668, 0, 0, 0, 0,
> .4354887230],
> [0, 0, 0, 0, 0, 0, 0, 0, .2693082916, .2523505370, .2454667568, 0, 
0, 0, 0,
> .2328744147],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .7434449438, .2565550562, 0, 0, 
0]]):
> 
> 
> M10 := array([
> [0, .3763379579, .3940844388, .2295776033, 0, 0, 0, 0, 0, 0, 0, 0, 
0, 0, 0,
> 0],
> [0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .2201397847, 0, .7798602153, 0, 0, 0, 0, 0, 0, 
0],
> [.9186737462e-1, 0, 0, 0, 0, 0, 0, .4717620312, 0, .4363705942, 0, 
0, 0, 0, 0,
> 0],
> [0, .2511855632, .2560833318, 0, 0, 0, 0, 0, 0, 0, 0, .2469097645,
> .2458213404, 0, 0, 0],
> [0, .5344177894, 0, 0, 0, 0, 0, 0, 0, 0, 0, .4655822106, 0, 0, 0, 
0],
> [0, .5589743590, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .4410256410, 0, 0, 
0],
> [0, 0, .2804465349, 0, 0, 0, 0, 0, 0, 0, 0, .1486031707, 0, 0, .
5709502944,
> 0],
> [0, 0, .3063290159, 0, 0, 0, 0, 0, 0, 0, 0, 0, .2227846698, 0, .
4708863144,
> 0],
> [0, 0, 0, .3272637965, .1969734550, 0, 0, 0, 0, 0, 0, 0, 0, .
4466042868e-1,
> .4311023198, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .3482377336, .3628021978, 0, 0, 0, 0, 0, 0, 0,
> .2889600686],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .2884117620, .2832283500, 0, .
4283598879,
> 0]]):
> 
> M11 := array([
> [0, .2055973783, .3724433778, 0, .4219592439, 0, 0, 0, 0, 0, 0, 0, 
0, 0, 0,
> 0],
> [0, 0, 0, 0, 0, .3881860759, .1402949367, .4715189873, 0, 0, 0, 0, 
0, 0, 0,
> 0],
> [0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [.4452710826, 0, 0, 0, 0, 0, .5547289174, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .4632465984e-1, .9536753402, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .2758620690, 0, .7241379310, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .5774809365, .4225190635, 0, 
0],
> [0, 0, .4863243797, .1025581844e-1, 0, 0, 0, 0, 0, 0, 0, .
5011855081, 0, 0,
> .2234293786e-2, 0],
> [0, 0, .2818533557e-1, 0, .1409310896, 0, 0, 0, 0, 0, 0, 0, .
8308835748, 0,
> 0,0],
> [0, 0, 0, .7426932971e-2, .4627575362, 0, 0, 0, 0, 0, 0, 0, 0, .
5298155309, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, .4108437982, 0, 0, 0, 0, 0, .
5891562018],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]]):
> 
> M12 := array([
> [0, 0, .9346581030, .6534189695e-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, .4264739619, .5735260381, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, .9254144471, 0, .7458555294e-1, 0, 0, 0, 0, 
0],
> [.1376396351, 0, 0, 0, 0, 0, 0, 0, 0, .6544952910, .2078650739, 0, 
0, 0, 0,
> 0],
> [0, .2813105007, .3794257798, 0, 0, 0, 0, 0, 0, 0, 0, .3357406613,
> .3523058201e-2, 0, 0, 0],
> [0, .2961777699, 0, .3408000727, 0, 0, 0, 0, 0, 0, 0, .3511111149, 
0,
> .1191104254e-1, 0, 0],
> [0, .4799628903, 0, 0, .5200371097, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, .8880647319e-2, 0, .9649207504, 0, 0, 0, 0, 0,
> .2619860231e-1],
> [0, 0, 0, 0, 0, 0, 0, .2099999580e-1, 0, 0, .9385000123, 0, 0, 0, 0,
> .4049999190e-1],
> [0, 0, 0, 0, 0, 0, 0, 0, .3445074599, .3460812087, .2960339943, 0, 
0, 0, 0,
> .1337733711e-1],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0]]):
> 
> 
> M13 := array([
> [0, 0, .3671914961, .6328085039, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0],
> [.6310357404e-1, 0, 0, 0, 0, .7952341508e-1, .8573730109, 0, 0, 0, 
0, 0, 0, 0,
> 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .5900874016e-1, 0, .3867230967, 0, .5542681631, 
0, 0, 0, 0,
> 0],
> [.7749078635e-1, 0, 0, 0, 0, 0, 0, .3173424823e-1, 0, .2714021803,
> .6193727851, 0, 0, 0, 0, 0],
> [0, 0, .6252319574, 0, 0, 0, 0, 0, 0, 0, 0, .1808906052, .
1938774374, 0, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, .3198078821e-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .4409590842, .
5270601276, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0],
> [0, 0, .1514360313, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .8485639687, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0],
> [0, 0, 0, 0, 0, 0, .2841514484, 0, .3277700228, 0, 0, 0, 0, 0, 0,
> .3880785288],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, .1752484192, 0, 0, 0, 0, 0, .
8247515808],
> [0, 0, 0, 0, 0, 0, .2738393248, 0, 0, 0, .3431098415, 0, 0, 0, 0,
> .3830508337],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]]):
> 
> M14 := array([
> [0, .4878056712e-1, .5826562320, 0, .3685632009, 0, 0, 0, 0, 0, 0, 
0, 0, 0, 0,
> 0],
> [0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0],
> [.7146233157, 0, 0, 0, 0, 0, 0, 0, .2853766843, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0],
> [0, .2272393379, .5188744354, 0, 0, 0, 0, 0, 0, 0, 0, 0, .
2538862267, 0, 0,
> 0],
> [0, .4851816444, 0, .4311663480, 0, 0, 0, 0, 0, 0, 0, .
8365200765e-1, 0, 0, 0,
> 0],
> [0, .2448783435, 0, 0, .4751213756, 0, 0, 0, 0, 0, 0, 0, .
2800002810, 0, 0,
> 0],
> [0, 0, 1.000000000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, .4524163380, .5472537264, 0, 0, 0, 0, 0, 0, 0, 0, 0, .
3299356101e-3,
> 0],
> [0, 0, 0, 0, 0, .4901439176, 0, 0, .5098560824, 0, 0, 0, 0, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .3002414053e-1, .9220602935, 0, 0, .
1821094940e-1, 0, 0, 0,
> 0, .2970461658e-1],
> [0, 0, 0, 0, 0, 0, 0, 0, .4274193548, .5675030466, 0, 0, 0, 0, 0,
> .5077598566e-2],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .1457872968, .8542127032, 0, 0, 
0]]):
> 
> M15 := array([
> [1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [.2126650661, 0, 0, 0, 0, .2715882271, .3616662982, .1540804086, 0, 
0, 0, 0,
> 0, 0, 0, 0],
> [.1464604894, 0, 0, 0, 0, .2880389624, 0, 0, .2066723493, .
3588281989, 0, 0,
> 0, 0, 0, 0],
> [.1350114542, 0, 0, 0, 0, 0, .3867275270, 0, .1773457113, 0, .
3009153075, 0,
> 0, 0, 0, 0],
> [.3565579988e-1, 0, 0, 0, 0, 0, 0, 0, 0, .4586709351, .5056732651, 
0, 0, 0, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, .3215852743, .6784147257, 0, 0, 
0],
> [0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, .1723751063, 0, 0, 0, 0, 0, 0, 0, .5719170248, .
2557078689, 0,
> 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0],
> [0, 0, 0, 0, 0, 0, .2834074301, 0, 0, 0, 0, 0, 0, 0, 0, .
7165925699],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1.000000000],
> [0, 0, 0, 0, 0, 0, .2964940265, 0, 0, 0, .1821648279, 0, 0, 0, 0,
> .5213411455],
> [0, 0, 0, 0, 0, 0, 0, 0, .2255064695, .2427255817, .2453959679, 0, 
0, 0, 0,
> .2863719809],
> [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]]):
> 
> 
> 
> N1 := array([],1..16,1..16):
> N2 := array([],1..16,1..16):
> N3 := array([],1..16,1..16):
> N4 := array([],1..16,1..16):
> N5 := array([],1..16,1..16):
> N6 := array([],1..16,1..16):
> N7 := array([],1..16,1..16):
> N8 := array([],1..16,1..16):
> N9 := array([],1..16,1..16):
> N10 := array([],1..16,1..16):
> N11 := array([],1..16,1..16):
> N12 := array([],1..16,1..16):
> N13 := array([],1..16,1..16):
> N14 := array([],1..16,1..16):
> N15 := array([],1..16,1..16):
> 
> for i from 1 to 16 do for j from 1 to 16 do
> N1[i,j] := M1[i,j]*cat(an[1],`_`,labels2[i][],`_`,labels2[j][]):
> N2[i,j] := M2[i,j]*cat(an[2],`_`,labels2[i][],`_`,labels2[j][]):
> N3[i,j] := M3[i,j]*cat(an[3],`_`,labels2[i][],`_`,labels2[j][]):
> N4[i,j] := M4[i,j]*cat(an[4],`_`,labels2[i][],`_`,labels2[j][]):
> N5[i,j] := M5[i,j]*cat(an[5],`_`,labels2[i][],`_`,labels2[j][]):
> N6[i,j] := M6[i,j]*cat(an[6],`_`,labels2[i][],`_`,labels2[j][]):
> N7[i,j] := M7[i,j]*cat(an[7],`_`,labels2[i][],`_`,labels2[j][]):
> N8[i,j] := M8[i,j]*cat(an[8],`_`,labels2[i][],`_`,labels2[j][]):
> N9[i,j] := M9[i,j]*cat(an[9],`_`,labels2[i][],`_`,labels2[j][]):
> N10[i,j] := M10[i,j]*cat(an[10],`_`,labels2[i][],`_`,labels2[j][]):
> N11[i,j] := M11[i,j]*cat(an[11],`_`,labels2[i][],`_`,labels2[j][]):
> N12[i,j] := M12[i,j]*cat(an[12],`_`,labels2[i][],`_`,labels2[j][]):
> N13[i,j] := M13[i,j]*cat(an[13],`_`,labels2[i][],`_`,labels2[j][]):
> N14[i,j] := M14[i,j]*cat(an[14],`_`,labels2[i][],`_`,labels2[j][]):
> N15[i,j] := M15[i,j]*cat(an[15],`_`,labels2[i][],`_`,labels2[j][]):
> od: od:
> 
> 
> IdentityMatrix := array([],1..16,1..16):
> for i from 1 to 16 do
> for j from 1 to 16 do
> if (i = j) then IdentityMatrix[i,j] := 1: else 
IdentityMatrix[i,j] := 0: fi:
> od:od:
> 
> choices := [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15]:
> length2 := cartprod([choices,choices]):
> length3 := cartprod([choices,choices,choices]):
> length4 := cartprod([choices,choices,choices,choices]):
> length5 := cartprod([choices,choices,choices,choices,choices]):
> length6 := 
cartprod([choices,choices,choices,choices,choices,choices]):
> 
> for L in [ length2,length3,length4,length5,length6 ] do
> 
> winners := [[0,{}],[0,{}],[0,{}],[0,{}],[0,{}],[0,{}],[0,{}],[0,{}],
> [0,{}],[0,{}],[0,{}],[0,{}],[0,{}],[0,{}],[0,{}],[0,{}]]:
> 
> while not L[finished] do seqq := L[nextvalue]():
> R := IdentityMatrix:
> for i from 1 to nops(seqq) do R := multiply(R,cat(M,seqq[i])): od:
> # lprint(seqq,time());
> for gg from 2 to 16 do
> if (R[gg,1] > winners[gg][1]) then
> winners[gg][1] := R[gg,1]:
> winners[gg][2] := {seqq}:
> fi:
> if (R[gg,1] = winners[gg][1]) then
> winners[gg][2] := winners[gg][2] union {seqq}:
> fi:
> od:
> end do:
> 
> pathways := {}:
> 
> for gg from 2 to 16 do
> if (winners[gg][1]=0) then winners[gg][1] := NONE: winners[gg][2] := 
{}: fi:
> print(` `);
> 
> lprint(labels2[gg],evalf(winners[gg][1])=winners[gg]
[1],nops(winners[gg][2]));
> druglabels := {}:
> for seqq in winners[gg][2] do uu := []:
> for i from 1 to nops(seqq) do uu := [uu[],an[seqq[i]]]: od:
> druglabels := druglabels union {uu}:
> 
> R := IdentityMatrix:
> for i from 1 to nops(seqq) do R := multiply(R,cat(N,seqq[i])): od:
> genfct := expand(R[gg,1]):
> mypathways := {}:
> if (type(genfct,monomial)) then
> mypathways := mypathways union {genfct}:
> else
> for j from 1 to nops(genfct) do
> mypathways := mypathways union {op(j,genfct)}:
> od:
> fi:
> lprint(uu,nops(mypathways));
> for mm in mypathways do lprint(mm); od:
> pathways := pathways union mypathways:
> od:
> od:
> 
> print(` `); lprint(`Transitions used in optimal pathways:`);
> 
> for transition in indets(pathways) do
> count := 0:
> for pp in pathways do
> if (member(transition,indets(pp))) then count := count + 1: fi:
> od:
> lprint(transition,count);
> od:
> print(time());
> 
> od:
> 
> 
                                       
[1, 0, 0, 0], 1.000000000 = 1.000000000, 3 [CTT, CPR], 1
1.000000000*CTT_1000_1000*CPR_1000_0000 [CPR, FEP], 1
1.000000000*CPR_1000_0000*FEP_0000_0000 [TZP, CPR], 1
1.000000000*TZP_1000_1000*CPR_1000_0000
                                       
[0, 1, 0, 0], .6171861963 = .6171861963, 6 [AM, FEP], 1
.6171861963*AM_0100_0000*FEP_0000_0000 [CEC, AM], 1
.6171861963*CEC_0100_0100*AM_0100_0000 [CXM, AM], 1
.6171861963*CXM_0100_0100*AM_0100_0000 [CRO, AM], 1
.6171861963*CRO_0100_0100*AM_0100_0000 [AMC, AM], 1
.6171861963*AMC_0100_0100*AM_0100_0000 [CTT, AM], 1
.6171861963*CTT_0100_0100*AM_0100_0000
                                       
[0, 0, 1, 0], .7146233157 = .7146233157, 2 [AM, TZP], 1
.7146233157*AM_0010_0010*TZP_0010_0000 [TZP, FEP], 1
.7146233157*TZP_0010_0000*FEP_0000_0000
                                       
[0, 0, 0, 1], .2871466592 = .2871466592, 1 [CEC, FEP], 1
